status: 200
content-location: http://rest.kegg.jp/get/map05205
server: Apache
date: Wed, 15 Oct 2014 15:09:29 GMT
content-type: text/plain

ENTRY       map05205                    Pathway
NAME        Proteoglycans in cancer
DESCRIPTION Many proteoglycans (PGs) in the tumor microenvironment have been shown to be key macromolecules that contribute to biology of various types of cancer including proliferation, adhesion, angiogenesis and metastasis, affecting tumor progress. The four main types of proteoglycans include hyaluronan (HA), which does not occur as a PG but in free form, heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), dematan sulfate proteoglycans (DSPG) and keratan sulfate proteoglycans (KSPGs) [BR:00535]. Among these proteoglycans such as HA, acting with CD44, promotes tumor cell growth and migration, whereas other proteoglycans such as syndecans (-1~-4), glypican (-1, -3) and perlecan may interact with growth factors, cytokines, morphogens and enzymes through HS chains [BR: 00536], also leading to tumor growth and invasion. In contrast, some of the small leucine-rich proteolgycans, such as decorin and lumican, can function as tumor repressors, and modulate the signaling pathways by the interaction of their core proteins and multiple receptors.
CLASS       Human Diseases; Cancers
PATHWAY_MAP map05205  Proteoglycans in cancer
REFERENCE   PMID:18450475
  AUTHORS   Bourguignon LY
  TITLE     Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.
  JOURNAL   Semin Cancer Biol 18:251-9 (2008)
REFERENCE   PMID:12729888
  AUTHORS   Briggs MW, Sacks DB
  TITLE     IQGAP1 as signal integrator: Ca2+, calmodulin, Cdc42 and the cytoskeleton.
  JOURNAL   FEBS Lett 542:7-11 (2003)
REFERENCE   PMID:12748184
  AUTHORS   Bourguignon LY, Singleton PA, Zhu H, Diedrich F
  TITLE     Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
  JOURNAL   J Biol Chem 278:29420-34 (2003)
REFERENCE   PMID:15655247
  AUTHORS   Bourguignon LY, Gilad E, Rothman K, Peyrollier K
  TITLE     Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
  JOURNAL   J Biol Chem 280:11961-72 (2005)
REFERENCE   PMID:11717317
  AUTHORS   Turley EA, Noble PW, Bourguignon LY
  TITLE     Signaling properties of hyaluronan receptors.
  JOURNAL   J Biol Chem 277:4589-92 (2002)
REFERENCE   PMID:9346940
  AUTHORS   Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC
  TITLE     Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.
  JOURNAL   J Biol Chem 272:27913-8 (1997)
REFERENCE   PMID:22735579
  AUTHORS   Neill T, Schaefer L, Iozzo RV
  TITLE     Decorin: a guardian from the matrix.
  JOURNAL   Am J Pathol 181:380-7 (2012)
REFERENCE   PMID:22194599
  AUTHORS   Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, Iozzo RV
  TITLE     Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.
  JOURNAL   J Biol Chem 287:5492-506 (2012)
REFERENCE   PMID:19433454
  AUTHORS   Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV
  TITLE     Decorin is a novel antagonistic ligand of the Met receptor.
  JOURNAL   J Cell Biol 185:743-54 (2009)
REFERENCE   PMID:15994311
  AUTHORS   Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV
  TITLE     Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.
  JOURNAL   J Biol Chem 280:32468-79 (2005)
REFERENCE   PMID:20974860
  AUTHORS   Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV
  TITLE     Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.
  JOURNAL   J Biol Chem 285:42075-85 (2010)
REFERENCE   PMID:18798267
  AUTHORS   Goldoni S, Iozzo RV
  TITLE     Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.
  JOURNAL   Int J Cancer 123:2473-9 (2008)
REFERENCE   PMID:23058688
  AUTHORS   Sofeu Feugaing DD, Gotte M, Viola M
  TITLE     More than matrix: the multifaceted role of decorin in cancer.
  JOURNAL   Eur J Cell Biol 92:1-11 (2013)
REFERENCE   PMID:22087031
  AUTHORS   Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, Tralhao JG, Lemarchand P, Pfeilschifter J, Schaefer RM, Iozzo RV, Schaefer L
  TITLE     Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21.
  JOURNAL   Sci Signal 4:ra75 (2011)
REFERENCE   PMID:22033227
  AUTHORS   Teng YH, Aquino RS, Park PW
  TITLE     Molecular functions of syndecan-1 in disease.
  JOURNAL   Matrix Biol 31:3-16 (2012)
REFERENCE   PMID:11830493
  AUTHORS   Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST
  TITLE     Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
  JOURNAL   Blood 99:1405-10 (2002)
REFERENCE   PMID:19733083
  AUTHORS   Fux L, Ilan N, Sanderson RD, Vlodavsky I
  TITLE     Heparanase: busy at the cell surface.
  JOURNAL   Trends Biochem Sci 34:511-9 (2009)
REFERENCE   PMID:18812315
  AUTHORS   Purushothaman A, Chen L, Yang Y, Sanderson RD
  TITLE     Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.
  JOURNAL   J Biol Chem 283:32628-36 (2008)
REFERENCE   PMID:19255147
  AUTHORS   Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC
  TITLE     Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.
  JOURNAL   J Exp Med 206:691-705 (2009)
REFERENCE   PMID:20655987
  AUTHORS   Mahtouk K, Tjin EP, Spaargaren M, Pals ST
  TITLE     The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.
  JOURNAL   Biochim Biophys Acta 1806:208-19 (2010)
REFERENCE   PMID:11931647
  AUTHORS   Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M
  TITLE     The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis  lung carcinoma-derived metastatic clones.
  JOURNAL   Biochem J 363:201-9 (2002)
REFERENCE   PMID:10687947
  AUTHORS   Nugent MA, Iozzo RV
  TITLE     Fibroblast growth factor-2.
  JOURNAL   Int J Biochem Cell Biol 32:115-20 (2000)
REFERENCE   PMID:10633082
  AUTHORS   Baciu PC, Saoncella S, Lee SH, Denhez F, Leuthardt D, Goetinck PF
  TITLE     Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization.
  JOURNAL   J Cell Sci 113 Pt 2:315-24 (2000)
REFERENCE   PMID:12509413
  AUTHORS   Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM
  TITLE     ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA.
  JOURNAL   J Biol Chem 278:9576-84 (2003)
REFERENCE   PMID:14711376
  AUTHORS   Beauvais DM, Rapraeger AC
  TITLE     Syndecans in tumor cell adhesion and signaling.
  JOURNAL   Reprod Biol Endocrinol 2:3 (2004)
REFERENCE   PMID:17971838
  AUTHORS   Morgan MR, Humphries MJ, Bass MD
  TITLE     Synergistic control of cell adhesion by integrins and syndecans.
  JOURNAL   Nat Rev Mol Cell Biol 8:957-69 (2007)
REFERENCE   PMID:18505598
  AUTHORS   Filmus J, Capurro M, Rast J
  TITLE     Glypicans.
  JOURNAL   Genome Biol 9:224 (2008)
REFERENCE   PMID:23305321
  AUTHORS   Filmus J, Capurro M
  TITLE     Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
  JOURNAL   FEBS J 280:2471-6 (2013)
REFERENCE   PMID:22563565
  AUTHORS   Gao W, Ho M
  TITLE     The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.
  JOURNAL   Cancer Rep 1:14-19 (2011)
REFERENCE   PMID:18413366
  AUTHORS   Cheng W, Tseng CJ, Lin TT, Cheng I, Pan HW, Hsu HC, Lee YM
  TITLE     Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
  JOURNAL   Carcinogenesis 29:1319-26 (2008)
REFERENCE   PMID:21155971
  AUTHORS   Iozzo RV, Sanderson RD
  TITLE     Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
  JOURNAL   J Cell Mol Med 15:1013-31 (2011)
REFERENCE   PMID:18949819
  AUTHORS   Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN
  TITLE     Lumican, a small leucine-rich proteoglycan.
  JOURNAL   IUBMB Life 60:818-23 (2008)
KO_PATHWAY  ko05205
///
